Protalix
NYSE: PLXKarmiel, IL · 2 known investors
Find your way into Protalix
Protalix is a biopharmaceutical company that develops and manufactures innovative pharmaceutical products, including treatments for orphan and rare diseases. The company leverages its proprietary technology platform and extensive expertise in drug development, regulatory affairs, and pharmaceutical manufacturing.
Founders & leadership
MB
Moshe BashanPresident and Chief Executive Officer
DB
Dror BashaninPresident and Chief Executive Officer, DirectorDror Bashan is President and CEO of Protalix, a biopharmaceutical company developing treatments for rare and orphan diseases using proprietary plant cell-based technology. He has over 20 years of experience in pharmaceutical and biotechnology sectors, including prior roles at Teva, with expertise in business development, finance, and drug regulatory approval processes.
Investors · 2
In the news
Frequently asked questions
- What does Protalix do?
- Protalix is a biopharmaceutical company that develops and manufactures innovative pharmaceutical products, including treatments for orphan and rare diseases. The company leverages its proprietary technology platform and extensive expertise in drug development, regulatory affairs, and pharmaceutical manufacturing.
- Who are Protalix's investors?
- Protalix's investors include Pontifax Venture Capital, Sofinnova Ventures.
- Where is Protalix headquartered?
- Protalix is headquartered in Karmiel, IL.